Companies / Amylyx Pharmaceuticals, Inc. / Activity

Activity — Amylyx Pharmaceuticals, Inc.

17 moves.

Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
InsidersInstitutions
DateActorActionSecurityValueShares ΔPosition afterImpact
Jan 15, 2026Cohen Joshua B
CEO
SellCommon Stock$1.85M-136K
-3.87%
3,378,621
3.03% of shares
medium
Jan 15, 2026Klee Justin B.
CEO
SellCommon Stock$1.85M-136K
-3.87%
3,378,546
3.03% of shares
medium
Mar 2, 2026Cohen Joshua B
CEO
SellCommon Stock$424.1K-29K
-0.87%
3,334,683
2.99% of shares
medium
Mar 2, 2026Klee Justin B.
CEO
SellCommon Stock$423.8K-29K
-0.87%
3,334,616
2.99% of shares
medium
Feb 2, 2026Klee Justin B.
CEO
SellCommon Stock$227.6K-16K
-0.46%
3,363,898
3.02% of shares
medium
Feb 2, 2026Cohen Joshua B
CEO
SellCommon Stock$227.6K-16K
-0.46%
3,363,965
3.02% of shares
medium
Mar 2, 2026Frates James M
Executive
SellCommon Stock$114.9K-8K
-4.56%
165,638
0.15% of shares
medium
Mar 2, 2026Mazzariello Gina
Executive
SellCommon Stock$99.4K-7K
-4.84%
134,430
0.12% of shares
low
Mar 2, 2026Bedrosian Camille L
Executive
SellCommon Stock$94.2K-6K
-3.68%
169,295
0.15% of shares
low
Jan 6, 2026Cohen Joshua B
CEO
SellCommon Stock$85.6K-8K
-0.23%
3,317,632
2.98% of shares
low
Jan 6, 2026Klee Justin B.
CEO
SellCommon Stock$85.6K-8K
-0.23%
3,317,586
2.98% of shares
low
Feb 2, 2026Frates James M
Executive
SellCommon Stock$52.1K-4K
-2.01%
173,547
0.16% of shares
low
Feb 2, 2026Mazzariello Gina
Executive
SellCommon Stock$50.5K-3K
-2.33%
144,693
0.13% of shares
low
Feb 23, 2026Mazzariello Gina
Executive
SellCommon Stock$48.4K-3K
-2.36%
141,274
0.13% of shares
low
Jan 6, 2026Frates James M
Executive
SellCommon Stock$37.0K-3K
-1.84%
177,104
0.16% of shares
low
Jan 16, 2026Klee Justin B.
CEO
SellCommon Stock$27.7K-2K
-0.06%
3,379,398
3.03% of shares
low
Jan 16, 2026Cohen Joshua B
CEO
SellCommon Stock$27.3K-2K
-0.06%
3,379,465
3.03% of shares
low
← PrevPage 1 of 1Next →